|
TIMTEC INC,
DE—TimTec Inc. is expressing
customer and business partner
appreciation as the company marks
10-years anniversary on the market of
early drug-discovery.
Ten years in
business, TimTec has matured into an
internationally recognized expert in
comprising diversity and targeted
library collections tailored to
drug discovery trends.
Presently the
company features its premier
libraries: grand in diversity
screening collection ActiMol-25K,
50K, or 70K; drug-like and diverse
in chemotypes ActiProbe-10K;
attractive in price and value
ScreenStart-5K; Natural Product
Library of pure compounds and plant
extract; and targeted
libraries (Kinase Modulators, GPCR
Ligands, Anti-infectives, Potassium
Channel Modulators, and Protease
Inhibitors).
TimTec maintains
extensive network of partners and
suppliers worldwide to ensure the
delivery of best products and services
to its customers. MyriaScreen
Diversity Collection of compounds
with distinct drug-like properties is
the successful result of the
collaboration with Sigma-Aldrich
Corporation.
TimTec
, Inc. evolved from a venture started
by the Zelinsky Institute of Organic
Chemistry (ZIOC) in
Russia
in the late 1980’s. Tremendous
growth opportunities in the bio-based
industry prompted the management to
establish operations in
U.S.
and expand further servicing customers
world-wide. In 1995 the company
incorporated in DE. During this
timeframe the company had grown its
product lines to include organic and
synthetic compounds for HTS, building
blocks, natural products,
biotinylation reagents, specialty
chemicals, chromatography columns,
packing material, and chemical
database management software.
TimTec
offers custom synthesis, quality
control, and full compound management
services.
TimTec
goes on servicing bio-based industry
research always remaining flexible to
accommodate custom needs and
requirements.
For more
information about company products and
services please visit:
http://www.timtec.net
http://www.buyreagents.com
Press releases
on: PR.com,
BioScreening.net
|